Publicação: Evaluation of the progression and treatment of experimental periodontitis in rats subjected to chemotherapy with 5-fluorouracil
Carregando...
Data
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
Springer
Tipo
Artigo
Direito de acesso
Acesso restrito
Resumo
This study aimed to evaluate the progression and treatment of experimental periodontitis (EP) in rats treated with 5-fluorouracil (5-FU).One-hundred fifty rats were divided into groups: C-control, EP-EP induction, EP/scaling and root planing (SRP)-EP induction and SRP, 5-FU-systemic treatment with 5-FU, 5-FU/EP-systemic treatment with 5-FU and EP induction, and 5-FU/EP/SRP-systemic treatment with 5-FU, EP induction and SRP. Systemic treatment consisted of the administration of 80 and 40 mg/kg of 5-FU. The animals were euthanised at 7, 15 and 30 days. Histological and immunohistochemical analyses for the detection of the receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin (OPG) and tartrate-resistant acid phosphatase (TRAP) were performed at the furcation region. A histometric analysis was performed to evaluate the percentage of bone in the furcation region (PBF).In the 5-FU/EP and 5-FU/EP/SRP groups, there was less PBF, greater breakdown of periodontal tissues and increased immunostaining for RANKL compared with the EP and EP/SRP groups.It can be concluded that 5-FU aggravates PE progression, impairs the host response to SRP mechanical therapy and does not seem to cause changes in the healthy periodontium.
Descrição
Palavras-chave
Periodontitis, Rats, Bone resorption, Antineoplastic agents, Fluorouracil
Idioma
Inglês
Como citar
Supportive Care In Cancer. New York: Springer, v. 23, n. 7, p. 2007-2017, 2015.
